Saijo N - Search Results

1

Indirect-response model for the time course of leukopenia with anticancer drugs.

Minami H, Sasaki Y, Saijo N, Ohtsu T, Fujii H, Igarashi T, Itoh K. Minami H, et al. Among authors: saijo n. Clin Pharmacol Ther. 1998 Nov;64(5):511-21. doi: 10.1016/S0009-9236(98)90134-5. Clin Pharmacol Ther. 1998. PMID: 9834043

2

A limited sampling model for estimating pharmacokinetics of CPT-11 and its metabolite SN-38.

Sasaki Y, Mizuno S, Fujii H, Ohtsu T, Wakita H, Igarashi T, Itoh K, Sekine I, Miyata Y, Saijo N. Sasaki Y, et al. Among authors: saijo n. Jpn J Cancer Res. 1995 Jan;86(1):117-23. doi: 10.1111/j.1349-7006.1995.tb02996.x. Jpn J Cancer Res. 1995. PMID: 7737903 Free PMC article. Clinical Trial.

3

Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes.

Saijo N, Nishio K, Ohta S, Arioka H, Funayama Y, Fukuoka K, Kurokawa H, Nomoto T, Ishida T, Yamamoto N, Tamura T, Shinkai T, Eguchi K, Ohe Y, Kunito H, Ohtsu T, Sasaki Y. Saijo N, et al. Cancer Chemother Pharmacol. 1996;38 Suppl:S11-5. doi: 10.1007/s002800051030. Cancer Chemother Pharmacol. 1996. PMID: 8765409 Review. No abstract available.

4

Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.

Ohtsu T, Sasaki Y, Tamura T, Miyata Y, Nakanomyo H, Nishiwaki Y, Saijo N. Ohtsu T, et al. Among authors: saijo n. Clin Cancer Res. 1995 Jun;1(6):599-606. Clin Cancer Res. 1995. PMID: 9816021 Clinical Trial.

5

Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) administered once a day for five consecutive days: a phase I study.

Kurata T, Tamura T, Sasaki Y, Fujii H, Negoro S, Fukuoka M, Saijo N. Kurata T, et al. Among authors: saijo n. Jpn J Clin Oncol. 2000 Sep;30(9):377-84. doi: 10.1093/jjco/hyd102. Jpn J Clin Oncol. 2000. PMID: 11095134 Clinical Trial.

6

Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.

Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, Ohe Y, Kojima A, Saijo N. Sasaki Y, et al. Among authors: saijo n. Cancer Res. 1991 Mar 1;51(5):1472-7. Cancer Res. 1991. PMID: 1997185 Clinical Trial.

7

A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38.

Sasaki Y, Hakusui H, Mizuno S, Morita M, Miya T, Eguchi K, Shinkai T, Tamura T, Ohe Y, Saijo N. Sasaki Y, et al. Among authors: saijo n. Jpn J Cancer Res. 1995 Jan;86(1):101-10. doi: 10.1111/j.1349-7006.1995.tb02994.x. Jpn J Cancer Res. 1995. PMID: 7737901 Free PMC article. Clinical Trial.

8

Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities.

Tamura T, Sasaki Y, Nishiwaki Y, Saijo N. Tamura T, et al. Among authors: saijo n. Jpn J Cancer Res. 1995 Dec;86(12):1203-9. doi: 10.1111/j.1349-7006.1995.tb03316.x. Jpn J Cancer Res. 1995. PMID: 8636011 Free PMC article. Clinical Trial.

9

Response rate as an endpoint for evaluating new cytotoxic agents in phase II trials of non-small-cell lung cancer.

Sekine I, Kubota K, Nishiwaki Y, Sasaki Y, Tamura T, Saijo N. Sekine I, et al. Among authors: saijo n. Ann Oncol. 1998 Oct;9(10):1079-84. doi: 10.1023/a:1008473003445. Ann Oncol. 1998. PMID: 9834819 Free article.

10

Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.

Miya T, Sasaki Y, Karato A, Saijo N. Miya T, et al. Among authors: saijo n. Jpn J Cancer Res. 1992 Dec;83(12):1382-5. doi: 10.1111/j.1349-7006.1992.tb02773.x. Jpn J Cancer Res. 1992. PMID: 1336497 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

756 results

Search Page

Filters